Is your organization missing from this list? Reach out to Leyla Cakici, Strategic Alliance Partnership Manager, to learn more about the complimentary strategic partnership program: lcakici@mjhlifesciences.com
Relacorilant/Nab-Paclitaxel Is Convenient, Safe in Ovarian Cancer
Neoadjuvant Nivolumab Regimen Improves OS in Resectable NSCLC
Relacorilant Combo Boosts PFS in Resistant Ovarian Cancer
Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care